https://t.co/3Nl0UJj6xW— Dr. Ayoade Alakija (@yodifiji) April 4, 2021It should be emphasized this is just the first phase of human trials, involving only 48 participants.
However, that’s not stopped people from getting excited about the impressive result, and the fact this particular vaccine takes a new approach.Related: President Biden vowed to end the HIV epidemic by 2025 – but how realistic is that goal?It’s has been notoriously difficult to produce a vaccine against HIV because there are many strains of the virus and it rapidly mutates.This new vaccine has been shown to produce a precursor to HIV antibodies in 97% of subjects.